IQMD
Closed
Intelligent Medicine Acquisition Corp
11.04
0.00 (0.00%)
Last Update: 10 May 2023 16:30:00
Yesterday: 11.04
Day's Range: 11.04 - 11.04
Send
sign up or login to leave a comment!
When Written:
10.28
Intelligent Medicine Acquisition Corp is a special purpose acquisition company (SPAC) that was formed for the purpose of acquiring or merging with one or more businesses in the healthcare sector. The company was founded by Dr. Steven Gundry, a renowned heart surgeon and author of several books on health and wellness.
Intelligent Medicine Acquisition Corp was incorporated in Delaware in 2020 and went public on the NASDAQ stock exchange in February 2021, raising $143 million in its initial public offering (IPO). The company's management team includes experienced healthcare executives and investors, including Dr. Gundry, who serves as the Chairman of the Board.
The company's mission is to identify and acquire a target business in the healthcare industry that has the potential for significant growth and value creation. Intelligent Medicine Acquisition Corp is focused on companies that are developing innovative products or services that address unmet medical needs, improve patient outcomes, and reduce healthcare costs.
As a SPAC, Intelligent Medicine Acquisition Corp has a two-year window to identify and complete a merger or acquisition. If the company is unable to find a suitable target within this timeframe, it will return the funds raised in its IPO to its shareholders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Intelligent Medicine Acquisition Corp was incorporated in Delaware in 2020 and went public on the NASDAQ stock exchange in February 2021, raising $143 million in its initial public offering (IPO). The company's management team includes experienced healthcare executives and investors, including Dr. Gundry, who serves as the Chairman of the Board.
The company's mission is to identify and acquire a target business in the healthcare industry that has the potential for significant growth and value creation. Intelligent Medicine Acquisition Corp is focused on companies that are developing innovative products or services that address unmet medical needs, improve patient outcomes, and reduce healthcare costs.
As a SPAC, Intelligent Medicine Acquisition Corp has a two-year window to identify and complete a merger or acquisition. If the company is unable to find a suitable target within this timeframe, it will return the funds raised in its IPO to its shareholders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!